DIA 2018 Editor’s Take – Synteract

Thought Leader:

Lisa Dilworth, VP, Rare and Orphan Diseases, Synteract

July 25, 2018      

Ms. Dilworth discusses the key challenges in operationalizing rare disease trials, the most exciting trends in rare disease trials, and what drives her to work in the rare disease space.

For more information please visit www.synteract.com/.

Post a Comment

You must be logged in to post a Comment.